AEGiS-SAPA: Govt looks at dual HIV-prevention strategy South African Press AssociationImportant note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow


Govt looks at dual HIV-prevention strategy

South African Press Association - July 31, 2007


The Health Department is preparing to introduce dual therapy to improve prevention of mother-to-child transmission of HIV. The National Strategic Plan for HIV and Aids and Sexually Transmitted Infections -- adopted by Cabinet earlier this year -- allows for introducing dual therapy for reducing mother-to-child transmission, the department said in a statement on Tuesday.

Furthermore, the move from single-dose nevirapine to dual therapy (Nevirapine and AZT) had been discussed by the National Health Council (NHC), which included the minister and provincial ministers of health. The discussions centred on recommendations by the Medical Research Council, National Essential Drugs Committee and the Medicines Control Council to move to dual therapy.

The NHC took a decision to evaluate the use of Nevirapine in reducing mother-to-child transmission of HIV. The NHC also considered implications for implementation, including training and capacity of health workers, adherence counselling and support to women. Further, work was now being done to improve guidelines and facilitate appropriate training for health workers, stock management, monitoring of resistance and information management for the introduction of such a therapy, the department said.


070731
SA070704


Copyright © 2007 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .